TRIM8 Activators
TRIM8 activators refer to a suite of chemicals that modulate the activity of the Tripartite Motif Containing 8 (TRIM8) protein, which is part of the larger TRIM family known for their roles in various cellular processes, including cell proliferation, differentiation, development, and oncogenesis. TRIM8, in particular, has been identified as a protein with an E3 ubiquitin ligase activity, suggesting its involvement in the ubiquitination pathway, a post-translational modification that can signal for protein degradation, localization, or activity modulation.
Direct activators of TRIM8 may interact with the protein to enhance its E3 ligase activity. This could involve binding to the catalytic site of the protein, therefore increasing its affinity for E2 ubiquitin-conjugating enzymes or ubiquitin itself, or by promoting the interaction between TRIM8 and its specific substrates. The result of such activation is an increased ubiquitination of target proteins that are recognized by TRIM8, which can alter their stability, activity, or interactions within the cell. Indirect activators, on the other hand, may not bind directly to TRIM8 but instead influence its activity by altering the expression levels of TRIM8, modulating its post-translational modifications, or affecting the availability of its substrates. For example, a molecule that increases the transcription of the TRIM8 gene would result in a higher concentration of the TRIM8 protein within the cell, potentially leading to increased E3 ligase activity. Alternatively, an indirect activator could inhibit deubiquitinating enzymes that target TRIM8 substrates, thereby enhancing the functional consequences of TRIM8's ubiquitination activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels in cells. As TRIM8 is known to be regulated by cAMP-dependent protein kinase A (PKA), Forskolin's action can enhance TRIM8 activity by upregulating cAMP levels leading to increased PKA activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a phosphodiesterase inhibitor that prevents the breakdown of cAMP, leading to an increase in intracellular cAMP levels. This can enhance the activity of PKA and subsequently increase the activity of TRIM8. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/AKT pathway, which in turn can enhance the activity of TRIM8. This is because TRIM8 activity has been associated with PI3K/AKT pathway activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. By inhibiting PI3K, it can increase the activity of TRIM8 indirectly as TRIM8 is known to be activated when the PI3K/AKT pathway is modulated. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that can downregulate the MAPK pathway. As TRIM8 is known to be activated in response to MAPK pathway downregulation, PD98059 can enhance the activity of TRIM8. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
SB203580 is a p38 MAPK inhibitor. By inhibiting p38 MAPK, it can enhance the activity of TRIM8 as TRIM8 is known to be activated when the MAPK pathway is modulated. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor. By inhibiting JNK, it can enhance the activity of TRIM8 as TRIM8 is known to be activated when the MAPK pathway is modulated. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. By inhibiting mTOR, it can enhance the activity of TRIM8 as TRIM8 is known to be activated when the mTOR pathway is modulated. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor that can lead to the downregulation of the PI3K/AKT pathway. This can enhance the activity of TRIM8 as TRIM8 is known to be activated when the PI3K/AKT pathway is modulated. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol is a known activator of Sirtuin 1, which can lead to the activation of the PI3K/AKT pathway. As TRIM8 has been shown to be activated by the PI3K/AKT pathway, Resveratrol can enhance TRIM8 activity. | ||||||